Informed-money record
IMDX · Insight Molecular Diagnostics Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
7
Bearish filings
0
Named actors
2
Disclosed $ (bull / bear)
$5.7M / $0
Recent disclosures
7 of 7 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-04-27 | 10% owner / other BROADWOOD PARTNERS, L.P. | bought | $913K | SEC ↗ |
| 2026-04-24 | 10% owner / other BROADWOOD PARTNERS, L.P. | bought | $137K | SEC ↗ |
| 2026-04-23 | 10% owner / other BROADWOOD PARTNERS, L.P. | bought | $982K | SEC ↗ |
| 2026-04-20 | 10% owner / other BROADWOOD PARTNERS, L.P. | bought | $158K | SEC ↗ |
| 2026-04-17 | 10% owner / other BROADWOOD PARTNERS, L.P. | bought | $143K | SEC ↗ |
| 2026-04-16 | 10% owner / other BROADWOOD PARTNERS, L.P. | bought | $352K | SEC ↗ |
| 2026-02-10 | 10% owner / other Bradsher Neal C | bought | $3.0M | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals